Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-21
2007-08-21
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S374000, C548S183000, C548S235000
Reexamination Certificate
active
10872871
ABSTRACT:
A novel process for the preparation of compounds of formula Iand optionally converting a compound of formula I into a pharmaceutically acceptable salt is disclosed. The compounds of formula I and the corresponding salts, e.g. the sodium salts, are pharmaceutically active substances. Processes for the creation of intermediates are also disclosed.
REFERENCES:
patent: 5599826 (1997-02-01), Mertens et al.
patent: 6441185 (2002-08-01), Kuhnle et al.
patent: WO94/27995 (1994-12-01), None
patent: WO 01/79202 (2001-10-01), None
Malamas, M.S. et al, Journal of Medicinal Chemistry, vol. 43, No. 5, (XP-002175477), pp. 995-1010 (2000).
Malamas, M.S. et al, Journal of Medicinal Chemistry, vol. 39, No. 1, (XP002093481), pp. 237-245 (1996).
Goehring Wolfgang
Hoffmann Ursula
Scalone Michelangelo
Stahr Helmut
Wang Shaoning
Anderson Rebecca
Hoffmann-La Roche Inc.
Johnston George W.
Rocha-Tramaloni Patricia S.
Young Shawquia
LandOfFree
Process for the preparation of the insulin sensitizer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the preparation of the insulin sensitizer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the preparation of the insulin sensitizer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3893543